EligibleTrials

Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

Recruiting · NCT05370014 · Interventional (participants receive a specific treatment) · Lead sponsor: University of South Carolina

View the official record on ClinicalTrials.gov →
Chronic kidney diseaseType 2 diabetes

Interventions studied

Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM)

What this trial is about

This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.